ArticleLipids in health and disease2025
The association between the intake of polyunsaturated fatty acids and chronic constipation and diarrhea: NHANES 2005-2010.
Article in Lipids in health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPolyunsaturated fatty acids (PUFAs) have shown notable protective effects in various diseases. This study aims to investigate the associations between PUFAs intake and both chronic constipation (CC) and chronic diarrhea (CD).
methodsData from three survey cycles (2005-2006, 2007-2008, and 2009-2010) of the National Health and Nutrition Examination Survey (NHANES) were used for analysis. 24-hour dietary recall interviews were employed to evaluate PUFAs intake. The associations between PUFAs intake and both CC and CD were analyzed via multivariable weighted logistic regression (WLR). Furthermore, stratified analysis and restricted cubic splines analysis were carried out.
results7723 participants were included, among whom 545 (8.35%) were CC patients and 579 (7.50%) were CD patients. According to the results of multivariable MLR, a nonlinear association between PUFAs intake and CC was found (P for nonlinear < 0.05), where the increased daily intake was related to a declined prevalence of CC [OR = 0.976 (0.959, 0.993), P = 0.007] in the fully adjusted model. However, there was no significant evidence of an association between PUFAs intake and CD (P > 0.05).
conclusionPUFAs intake was negatively associated with CC and was not strongly associated with CD. It suggested that adjusting daily PUFAs intake may alleviate CC symptoms.
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.